Domov › Nemalicelični pljučni rak › Florida › Miami
Klinične študije za Nemalicelični pljučni rak v Miami, FL
31 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Miami in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #47, Miami
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Vključevanje udeležencevFaza 3
- Miami Cancer Institute, Miami
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Vključevanje udeležencevFaza 3
- Sylvester Comprehensive Cancer Center Miami, Miami
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- Sylvester Comprehensive Cancer Center, Miami
- Baptist Health Miami Cancer Institute, Miami
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- University of Miami, Miami
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1/2
- Miami Cancer Institute, Miami
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Vključevanje udeležencevFaza 3
- Local Institution - 0696, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Sylvester Comprehensive Cancer Center, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Vključevanje udeležencevFaza 1
- Biogenix Molecular, LLC, Miami
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Miami Veterans Affairs Healthcare System, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- University of Miami, Miami
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Sylvester Comprehensive Cancer Center, Miami
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- University of Miami, Miami
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Vključevanje udeležencevFaza 3
- Miami Cancer Institute at Baptist Health, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- University of Miami, Miami
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center, Miami
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Vključevanje udeležencevFaza 2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Bioresearch Partner, Miami
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
A Study of VET3-TGI in Patients With Solid Tumors
Vključevanje udeležencevFaza 1
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Vključevanje udeležencevFaza 2
- Baptist Alliance - McI, Miami
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Vključevanje udeležencev
- Miami VA Healthcare System, Miami, FL, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Miami
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Vključevanje udeležencevOpazovalna študija
- Baptist Health South Florida, Miami
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY120 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH56 študij
- Washington, DC55 študij
Druge študije v Miami
- Rak dojke42 študij
- Rak (vse vrste)36 študij
- Rak prostate27 študij
- Debelost27 študij
- Akutna mieločna levkemija24 študij
- Metastatski rak24 študij
- Rak jajčnikov23 študij
- Prekomerna telesna teža23 študij
- Množni mielom21 študij
- Ulcerativni kolitis21 študij
- Alzheimerjeva bolezen20 študij
- Rak pljuč20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.